Jeff Martin
Stock Analyst at Roth MKM
(4.49)
# 267
Out of 4,479 analysts
40
Total ratings
60%
Success rate
17.69%
Average return
Main Sectors:
9 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FC Franklin Covey Co. | Reiterates: Buy | $50 | $38.24 | +30.75% | 6 | Jun 27, 2024 | |
| NVEE NV5 Global | Reiterates: Buy | $121 → $128 | $91.33 | +40.15% | 4 | May 9, 2024 | |
| BWMN Bowman Consulting Group | Maintains: Buy | $49 → $47 | $31.59 | +48.78% | 4 | May 8, 2024 | |
| OSIS OSI Systems | Maintains: Buy | $169 → $172 | $137.16 | +25.40% | 13 | Apr 26, 2024 | |
| PERI Perion Network | Downgrades: Neutral | $35 → $13 | $8.63 | +50.64% | 5 | Apr 9, 2024 | |
| NSP Insperity | Maintains: Buy | $144 → $147 | $90.19 | +62.99% | 3 | Apr 27, 2023 | |
| HCKT The Hackett Group | Maintains: Buy | n/a | $21.91 | - | 3 | Aug 12, 2021 | |
| BBSI Barrett Business Services | Maintains: Buy | n/a | $32.70 | - | 1 | Aug 5, 2021 | |
| GLMD Galmed Pharmaceuticals | Initiates: Buy | n/a | $0.29 | - | 1 | Nov 15, 2017 |
Franklin Covey Co.
Jun 27, 2024
Reiterates: Buy
Price Target: $50
Current: $38.24
Upside: +30.75%
NV5 Global
May 9, 2024
Reiterates: Buy
Price Target: $121 → $128
Current: $91.33
Upside: +40.15%
Bowman Consulting Group
May 8, 2024
Maintains: Buy
Price Target: $49 → $47
Current: $31.59
Upside: +48.78%
OSI Systems
Apr 26, 2024
Maintains: Buy
Price Target: $169 → $172
Current: $137.16
Upside: +25.40%
Perion Network
Apr 9, 2024
Downgrades: Neutral
Price Target: $35 → $13
Current: $8.63
Upside: +50.64%
Insperity
Apr 27, 2023
Maintains: Buy
Price Target: $144 → $147
Current: $90.19
Upside: +62.99%
The Hackett Group
Aug 12, 2021
Maintains: Buy
Price Target: n/a
Current: $21.91
Upside: -
Barrett Business Services
Aug 5, 2021
Maintains: Buy
Price Target: n/a
Current: $32.70
Upside: -
Galmed Pharmaceuticals
Nov 15, 2017
Initiates: Buy
Price Target: n/a
Current: $0.29
Upside: -